Merck, Allergan named as potential bidders for BiogenBiogen vulnerable to takeover as chief executive steps down Share XMerck, Allergan named as potential bidders for Biogenhttps://pharmaphorum.com/news/merck-allergan-named-potential-bidders-biogen/
Medivation hits back at Sanofi’s boardroom coup attemptSanofi has unveiled plans to replace the entire board of Medivation in order to push through its $9.3 Share XMedivation hits back at Sanofi’s boardroom coup attempthttps://pharmaphorum.com/news/medivation-hits-back-at-sanofis-boardroom-coup-attempt/